Moleculin Biotech, Inc. — Director's Dealing 2019

Jul 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2019-07-11

Reporting Person: CANNON MICHAEL D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-11	Stock option (right to buy)	$1.31	A	35000	Acquired	2029-07-11	Common Stock (35000.0)	Direct

Footnotes

F1: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.

F2: (2) The options were issued in connection with the reporting person's Board of Director service to the Company.